Global Pharmaceutical Caps and Closures Market to reach USD 66.66 billion by 2027.

Pharmaceutical Caps and Closures Market Size study, by Product Type (Screw-on Caps, Dispensing Caps and Others) by Technology (Injection Moulding, Compression Moulding, Post-mould TE Band, Others) By Raw Material (PP, HDPE, LDPE and others), By End-use (Beverage, Pharmaceuticals and others) and Regional Forecasts 2021-2027.
Product Code:  CAMP_57931898
Chapter 1.Executive Summary 
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2028 (USD Billion)
1.2.1.  Pharmaceutical Caps and Closures Market, by Region, 2019-2028 (USD Billion)
1.2.2.  Pharmaceutical Caps and Closures Market, by Type, 2019-2028 (USD Billion)
1.2.3.  Pharmaceutical Caps and Closures Market, by Technology, 2019-2028 (USD Billion)
1.2.4.  Pharmaceutical Caps and Closures Market, by Raw materials, 2019-2028 (USD Billion)

1.2.5.  Pharmaceutical Caps and Closures Market, by End use, 2019-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Global  Pharmaceutical Caps and Closures Market Definition and Scope 
1.6. The objective of the Study
1.7. Market Definition & Scope
1.7.1. Scope of the Study
1.7.2. Industry Evolution
1.8. Years Considered for the Study
1.9. Currency Conversion Rates
Global  Pharmaceutical Caps and Closures Market Dynamics 
1.10.  Pharmaceutical Caps and Closures Market Impact Analysis (2019-2028)
1.10.1. Market Drivers
1.10.1.1. Increasing adoption of COC 
1.10.1.2. Need for convenience and concerns about product safety & security 
1.10.2. Market Challenges
1.10.2.1. Mature markets in developed regions 
1.10.2.2. Development of substitutes 
1.10.3. Market Opportunities
1.10.3.1. Emerging economies 
Global Pharmaceutical Caps and Closures Market Industry Analysis
1.11. Porter’s 5 Force Model
1.11.1. Bargaining Power of Suppliers
1.11.2. Bargaining Power of Buyers
1.11.3. The threat of New Entrants
1.11.4. Threat of Substitutes
1.11.5. Competitive Rivalry
1.11.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
1.12. PEST Analysis
1.12.1. Political 
1.12.2. Economical
1.12.3. Social 
1.12.4. Technological 
1.13. Investment Adoption Model
1.14. Analyst Recommendation & Conclusion
Global  Pharmaceutical Caps and Closures Market, by Type 
1.1. Market Snapshot 
1.2. Global  Pharmaceutical Caps and Closures Market by Type, Performance - Potential Analysis
1.3. Global  Pharmaceutical Caps and Closures Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
1.4.  Pharmaceutical Caps and Closures Market, Sub Segment Analysis
1.4.1. Screw-on Caps, 
1.4.2. Dispensing Caps and
1.4.3.   Others
Global  Pharmaceutical Caps and Closures Market, by Raw material          
1.5. Market Snapshot 
1.6. Global  Pharmaceutical Caps and Closures Market by Application, Performance - Potential Analysis
1.7. Global  Pharmaceutical Caps and Closures Market Estimates & Forecasts by Application 2018-2028 (USD Billion)
1.8.  Pharmaceutical Caps and Closures Market, Sub Segment Analysis
1.8.1. PP, 
1.8.2. HDPE, 
1.8.3. LDPE and 
1.8.4. others
Global  Pharmaceutical Caps and Closures Market, by Technology         
1.9. Market Snapshot 
1.10. Global  Pharmaceutical Caps and Closures Market by Purchase Mode, Performance - Potential Analysis
1.11. Global  Pharmaceutical Caps and Closures Market Estimates & Forecasts by Purchase Mode 2018-2028 (USD Billion)
1.12.  Pharmaceutical Caps and Closures Market, Sub Segment Analysis
1.12.1. Injection Moulding, 
1.12.2. Compression Moulding, 
1.12.3. Post-mould TE Band, 
1.12.4. Others
Global  Pharmaceutical Caps and Closures Market, by End use         
1.13. Market Snapshot 
1.14. Global  Pharmaceutical Caps and Closures Market by Eye disease, Performance - Potential Analysis
1.15. Global  Pharmaceutical Caps and Closures Market Estimates & Forecasts by Eye disease 2018-2028 (USD Billion)
1.16.  Pharmaceutical Caps and Closures Market, Sub Segment Analysis
1.16.1.   Beverage, 
1.16.2. Pharmaceuticals and 
1.16.3. others
Global  Pharmaceutical Caps and Closures Market, Regional Analysis
1.17.  Pharmaceutical Caps and Closures Market, Regional Market Snapshot 
1.18. North America  Pharmaceutical Caps and Closures Market 
1.18.1. U.S.  Pharmaceutical Caps and Closures Market
1.18.1.1.  Type breakdown estimates & forecasts, 2018-2028 
1.18.1.2.  Application breakdown estimates & forecasts, 2018-2028 
1.18.1.3. Purchase mode breakdown estimates & forecasts, 2018-2028
1.18.1.4. Eye Disease breakdown estimates & forecasts, 2018-2028
1.18.2. Canada  Pharmaceutical Caps and Closures Market
1.19. Europe  Pharmaceutical Caps and Closures Market Snapshot
1.19.1. U.K.  Pharmaceutical Caps and Closures Market 
1.19.2. Germany  Pharmaceutical Caps and Closures Market
1.19.3. France  Pharmaceutical Caps and Closures Market
1.19.4. Spain  Pharmaceutical Caps and Closures Market
1.19.5. Italy  Pharmaceutical Caps and Closures Market
1.19.6. Rest of Europe  Pharmaceutical Caps and Closures Market
1.20. Asia-Pacific  Pharmaceutical Caps and Closures Market Snapshot
1.20.1. China  Pharmaceutical Caps and Closures Market 
1.20.2. India  Pharmaceutical Caps and Closures Market 
1.20.3. Japan  Pharmaceutical Caps and Closures Market
1.20.4. Australia  Pharmaceutical Caps and Closures Market
1.20.5. South Korea  Pharmaceutical Caps and Closures Market
1.20.6. Rest of Asia Pacific  Pharmaceutical Caps and Closures Market
1.21. Latin America  Pharmaceutical Caps and Closures Market Snapshot
1.21.1. Brazil  Pharmaceutical Caps and Closures Market
1.21.2. Mexico  Pharmaceutical Caps and Closures Market
1.22. Rest of The World  Pharmaceutical Caps and Closures Market

Competitive Intelligence
1.23. Top Market Strategies
1.24. Company Profiles
1.24.1. Pfizer Inc.
1.24.1.1. Key Information
1.24.1.2. Overview
1.24.1.3. Financial (Subject to Data Availability)
1.24.1.4. Product Summary
1.24.1.5. Recent Developments
1.24.2.   Rexam PLC (U.K),
1.24.3.  Berry Plastics Corporation (U.S.), 
1.24.4. AptarGroup Inc. (U.S.),
1.24.5.  RPC Group Plc. (U.K.), 
1.24.6. Crown Holdings Inc. (U.S.), 
1.24.7. Amcor Limited (Australia), 
1.24.8. Reynolds Group Holdings Limited (New Zealand), 
1.24.9.  Silgan Holdings Inc. (U.S.), 
1.24.10. Guala Closures Group (Italy), 
1.24.11.  BERICAP GmbH Co. & KG (Germany).
1.24.12. Tecnocap Sp
Research Process
1.25. Research Process
1.25.1. Data Mining
1.25.2. Analysis
1.25.3. Market Estimation
1.25.4. Validation
1.25.5. Publishing
1.26. Research Attributes
1.27. Research Assumption

Global Pharmaceutical Caps and Closures Market is valued at approximately USD 34.50 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 5.4% over the forecast period 2021-2027. The pharmaceutical caps and closures are utilized to keep the container closed and the contents contained for the specified shelf life. These packaging provide barrier to dirt, moisture and oxygen and keeps the product secure from undesired premature opening. Caps and closures industry use various types of materials to produce suitable product packaging including metals, rubber, paperboard and plastics among others. The rise in the development of child resistant and tamper evident packaging, increasing demand for convenience in pharmaceutical packaging and surge in the sales of pharmaceuticals products across the globe is escalating the growth of the pharmaceutical caps and closures market. The increasing adoption of cyclic olefin copolymer (COC) as these are known to be clear amorphous copolymers possessing unique combination of properties such as high transparency, low density and resistance to aqueous and polar organic media and the usage of COC as a raw material in the manufacturing of pharmaceutical caps and closures owning to their excellent barrier properties accelerate the pharmaceutical caps and closures market growth. The rising demand for halogen-free and environmentally-friendly such as COC and the utilization of other plastic materials including high-density polyethylene (HDPE), polyester and PP as raw materials in the construction of caps and closures because of their corrosion resistance, flexibility and lightweight influence the pharmaceutical caps and closures market. Additionally, need for convenience and concerns about product safety and security, and product differentiation and branding positively affect the pharmaceutical caps and closures market. Furthermore, technological advancement in the packaging solutions and the emerging economies extend profitable opportunities to the pharmaceutical caps and closures market players in the forecast period of 2021 to 2027.
On the other hand, development of substitutes is expected to obstruct the pharmaceutical caps and closures market growth. The concerns regarding the risks associated with biodegradability and carcinogenicity of plastics is projected to challenge the pharmaceutical caps and closures market in the forecast period of 2021 to 2027.

The regional analysis of the global Pharmaceutical caps and closures market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. APAC is the leading region across the world in terms of market share and is also anticipated to exhibit the highest CAGR over the forecast period 2021-2027. Factors such as the increase in the sale of self-medication and OTC drugs increasing population, industrialization, and urbanization are augmenting the plastic caps & closures market growth. China’s emergence as a global manufacturing hub has increased the demand for plastic caps & closures. Cheap labor and easy availability of raw materials boost the production of these products in the region.

Major market player included in this report are:
Pfizer Inc.
Rexam PLC (U.K),
Berry Plastics Corporation (U.S.),
AptarGroup Inc. (U.S.),
RPC Group Plc. (U.K.),
Crown Holdings Inc. (U.S.),
Amcor Limited (Australia),
Reynolds Group Holdings Limited (New Zealand),
Silgan Holdings Inc. (U.S.),
Guala Closures Group (Italy),
BERICAP GmbH Co. & KG (Germany).
Tecnocap Spa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Screw-on Caps,
Dispensing Caps and
Others
By Technology:
Injection Moulding,
Compression Moulding,
Post-mould TE Band,
Others
By Raw material:
PP,
HDPE,
LDPE
and others
By End use:
Beverage,
Pharmaceuticals and
others
By Region:
North America
The U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
Ro APAC
Latin America

Mexico
Rest of the World

Furthermore, the years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Urgent Care Centers Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…